Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Should Ambulatory Surgery and Day of Surgery Admission Patients Discontinue Angiotensin Converting Enzyme Inhibitors (ACEI's) and Angiotension Receptor Blockers (ARB's) Preoperatively?

NCT03121092 is registered in ClinicalTrials.gov with State University of New York - Downstate Medical Center as lead sponsor.

NCT NCT03121092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03121092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Should Ambulatory Surgery and Day of Surgery Admission Patients Discontinue Angiotensin Converting Enzyme Inhibitors (ACEI's) and Angiotension Receptor Blockers (ARB's) Preoperatively?
Lead sponsor
State University of New York - Downstate Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
May 16, 2012
Completion date
March 7, 2017
Enrollment
188 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hypotension